Funds and ETFs Clover Biopharmaceuticals, Ltd.
Equities
2197
KYG2280A1076
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.42 HKD | -3.45% | +16.67% | -32.26% |
12/04 | Clover Biopharmaceuticals, Ltd. announced that it has received $0.320713 million in funding | CI |
08/04 | Clover Biopharmaceuticals' RSV Vaccine Candidate Shows Promise in Early Trial | MT |
ETFs positioned on Clover Biopharmaceuticals, Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.69% | 4 M€ | -27.92% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-32.26% | 72.22M | |
+9.00% | 105B | |
-0.62% | 104B | |
+5.79% | 22.94B | |
-12.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.21% | 16.96B | |
+7.87% | 14.16B | |
+37.92% | 12.63B |
- Stock Market
- Equities
- 2197 Stock
- Funds and ETFs Clover Biopharmaceuticals, Ltd.